By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nordic Bioscience A/S 

Herlev Hovedgade 207

Herlev    2730  Denmark
Phone: 45-4452-5252 Fax: 45-4452-5251



Company News
Bristol-Myers Squibb (BMY) And Nordic Bioscience A/S Announce Collaboration For Fibrosis Biomarker Technology 4/17/2017 9:05:01 AM
Enteris Biopharma Release: Company Enters Into Agreement With Nordic Bioscience A/S's KeyBioscience To Develop Orally Delivered Metabolic Peptide 1/25/2017 7:21:01 AM
Symic Biomedical And Nordic Bioscience A/S Complete Enrollment Of MODIFY-OA Trial Of SB-061 For The Treatment Of Osteoarthritis 11/11/2016 11:09:02 AM
Symic Biomedical Announces Collaboration With Nordic Bioscience A/S For Its Osteoarthritis Program 1/5/2015 8:55:30 AM
Enteris Biopharma and Nordic Bioscience A/S's KeyBioScience Enter Strategic Licensing Agreement to Develop Metabolic Peptides Using Enteris' Proprietary Oral Drug Delivery and Manufacturing Platform 9/30/2013 10:03:48 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Enter Equity Transfer and Exclusive License Agreement for Proprietary Metabolic Peptide Analogs 5/9/2013 10:09:25 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Announce Preliminary Selection of Lead Compound for Treating Type 2 Diabetes 8/16/2012 10:48:35 AM
Unigene Laboratories, Inc. (UGNE) to Host Live Conference Call and Webcast to Discuss Collaboration with Nordic Bioscience A/S and Formation of Joint Development Vehicle 10/6/2011 10:08:00 AM
Unigene Laboratories, Inc. (UGNE) and Nordic Bioscience A/S Combine Industry Leading Capabilities to Advance Unigene's Proprietary Peptides through Phase 2 Proof-of-Concept for the Treatment of Type 2 Diabetes, Osteoarthritis and Osteoporosis 10/6/2011 9:54:50 AM
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT 7/23/2010 7:08:08 AM